• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

F-FDG PET/CT 检查所得基线身体成分参数对血管免疫母细胞性 T 细胞淋巴瘤患者的预后价值

Prognostic value of baseline body composition parameters from F-FDG PET/CT in angioimmunoblastic T-cell lymphoma patients.

作者信息

Gong Huanyu, Shang Jingjie, Li Jianyong, Ding Chongyang, Xu Hao, Tang Lijun, Cheng Yong

机构信息

Department of Nuclear Medicine, The First Affiliated Hospital of Jinan University, Guangzhou, China.

Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

出版信息

Ann Hematol. 2025 Aug 23. doi: 10.1007/s00277-025-06562-0.

DOI:10.1007/s00277-025-06562-0
PMID:40846802
Abstract

This retrospective study investigated preliminarily the prognostic value of body composition parameters derived from baseline F-FDG PET/CT in angioimmunoblastic T-cell lymphoma (AITL) patients. We included 94 treatment-naïve AITL patients diagnosed by histopathology. Based on the axial CT images of the third lumbar vertebra, the areas of skeletal muscle (SM), visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT) were semi-automatically delineated and standardized to finally obtain SM index (SMI), VAT index (VATI), and SAT index (SATI). Body composition density characterized by CT attenuation was obtained, including SM density (SMD), VAT density (VATD), and SAT density (SATD). Besides, the maximum standardized uptake value (SUVmax), total metabolic tumor volume (TMTV), and total lesion glycolysis (TLG) were also calculated. Endpoints included progression-free survival (PFS) and overall survival (OS). Survival curves and Cox regression analysis were performed‌‌.Of 94 AITL patients(mean age:63.4 ± 9.7 years,67% men), 65 progressed and 55 died[median follow-up: 27.5 (10.5-45.7) months].High baseline C-reactive protein level [hazard ratio (HR) = 2.47, 95%CI: 1.37-4.45, p = 0.003), low SMD (HR = 2.18, 95%CI:1.29-3.69, p = 0.003), high SATD (HR = 1.92, 95%CI: 1.05-3.54, p = 0.035), and low VATI (HR = 1.95, 95%CI: 1.12-3.38, p = 0.018) were independent risk factors for poor PFS. AITL score>2(HR = 2.90, 95%CI: 1.59-5.29, p < 0.001), sarcopenia(HR = 1.78, 95%CI: 1.01-3.12,p = 0.045), low VATI(HR = 2.24,95%CI: 1.27-3.95,p = 0.005), and high TMTV(HR = 2.46, 95%CI: 1.37-4.40, p = 0.003) may serve as independent risk factors for poor OS. In conclusion, in addition to conventional TMTV, body composition parameters derived from baseline F-FDG PET/CT may offer preliminary prognostic value for AITL patients.

摘要

这项回顾性研究初步探讨了基线F-FDG PET/CT得出的身体成分参数在血管免疫母细胞性T细胞淋巴瘤(AITL)患者中的预后价值。我们纳入了94例经组织病理学确诊的初治AITL患者。基于第三腰椎的轴向CT图像,半自动勾勒出骨骼肌(SM)、内脏脂肪组织(VAT)和皮下脂肪组织(SAT)的面积并进行标准化,最终得出SM指数(SMI)、VAT指数(VATI)和SAT指数(SATI)。获取以CT衰减为特征的身体成分密度,包括SM密度(SMD)、VAT密度(VATD)和SAT密度(SATD)。此外,还计算了最大标准化摄取值(SUVmax)、总代谢肿瘤体积(TMTV)和总病变糖酵解(TLG)。观察终点包括无进展生存期(PFS)和总生存期(OS)。进行了生存曲线和Cox回归分析。在94例AITL患者中(平均年龄:63.4±9.7岁,67%为男性),65例病情进展,55例死亡[中位随访时间:27.5(10.5 - 45.7)个月]。高基线C反应蛋白水平[风险比(HR)=2.47,95%置信区间:1.37 - 4.45,p = 0.003]、低SMD(HR = 2.18,95%置信区间:1.29 - 3.69,p = 0.003)、高SATD(HR = 1.92,95%置信区间:1.05 - 3.54,p = 0.035)和低VATI(HR = 1.95,95%置信区间:1.12 - 3.38,p = 0.018)是PFS不良的独立危险因素。AITL评分>2(HR = 2.90,95%置信区间:1.59 - 5.29,p < 0.001)、肌肉减少症(HR = 1.78,95%置信区间:1.01 - 3.12,p = 0.045).低VATI(HR = 2.24,95%置信区间:1.27 - 3.95,p = 0.005)和高TMTV(HR = 2.46,95%置信区间:1.37 - 4.40,p = 0.003)可能是OS不良的独立危险因素。总之,除了传统的TMTV外,基线F-FDG PET/CT得出的身体成分参数可能为AITL患者提供初步的预后价值

相似文献

1
Prognostic value of baseline body composition parameters from F-FDG PET/CT in angioimmunoblastic T-cell lymphoma patients.F-FDG PET/CT 检查所得基线身体成分参数对血管免疫母细胞性 T 细胞淋巴瘤患者的预后价值
Ann Hematol. 2025 Aug 23. doi: 10.1007/s00277-025-06562-0.
2
Total metabolic tumor volume on F-FDG PET/CT is a game-changer for patients with metastatic lung cancer treated with immunotherapy.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的总代谢肿瘤体积是免疫治疗转移性肺癌患者的改变游戏规则的因素。
J Immunother Cancer. 2024 Apr 22;12(4):e007628. doi: 10.1136/jitc-2023-007628.
3
Subcutaneous adipose tissue [F]FDG uptake and CT-derived body composition variables for predicting survival outcomes in patients with locally advanced gastric cancer.皮下脂肪组织的[F]FDG摄取及CT衍生的身体成分变量对局部晚期胃癌患者生存结局的预测作用
Eur J Nucl Med Mol Imaging. 2025 Apr 24. doi: 10.1007/s00259-025-07296-x.
4
Semiquantitative PET Parameters Refine Prognosis in CAR T-Treated Lymphoma After 1 and 3 Months: A Prospective Single-Center Study.半定量PET参数改善CAR-T治疗淋巴瘤1个月和3个月后的预后:一项前瞻性单中心研究
J Nucl Med. 2025 Apr 17. doi: 10.2967/jnumed.125.269670.
5
Prognostic Impact of Quantitative Changes Between Baseline and Interim 18 F-FDG PET/CT in Pediatric Classic Hodgkin Lymphoma.基线与中期18F-FDG PET/CT定量变化对儿童经典型霍奇金淋巴瘤的预后影响
Clin Nucl Med. 2025 Jul 1;50(7):e407-e416. doi: 10.1097/RLU.0000000000005874. Epub 2025 Mar 31.
6
Role of Metabolic Parameters of 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (18F-FDG PET-CT) Imaging in Predicting Progression-Free Survival of Radioiodine-Refractory Differentiated Thyroid Cancer: A Single-Center Study.18F-氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描(18F-FDG PET-CT)成像的代谢参数在预测放射性碘难治性分化型甲状腺癌无进展生存期方面的作用:一项单中心研究
Cureus. 2025 May 28;17(5):e84998. doi: 10.7759/cureus.84998. eCollection 2025 May.
7
A preliminary investigation of the relationship between F-FDG PET/CT metabolic parameters and prognosis in angioimmunoblastic T-cell lymphoma.F-FDG PET/CT代谢参数与血管免疫母细胞性T细胞淋巴瘤预后关系的初步研究
Front Oncol. 2023 Jun 15;13:1171048. doi: 10.3389/fonc.2023.1171048. eCollection 2023.
8
Feasibility analysis of metabolic parameters based on baseline F-FDG PET/CT to predict heterogeneity and recurrence of diffuse large B-cell lymphoma.基于基线F-FDG PET/CT代谢参数预测弥漫性大B细胞淋巴瘤异质性和复发的可行性分析
Ann Hematol. 2025 Jun 11. doi: 10.1007/s00277-025-06409-8.
9
Prognostic value of baseline total metabolic tumour volume of F-FDG PET/CT imaging in patients with angioimmunoblastic T-cell lymphoma.F-FDG PET/CT成像的基线总代谢肿瘤体积在血管免疫母细胞性T细胞淋巴瘤患者中的预后价值
EJNMMI Res. 2021 Jul 15;11(1):64. doi: 10.1186/s13550-021-00807-5.
10
The role of body composition and pulmonary function in predicting long-term survival after lung cancer surgery.身体成分和肺功能在预测肺癌手术后长期生存中的作用。
Clin Nutr ESPEN. 2025 Aug;68:140-147. doi: 10.1016/j.clnesp.2025.04.009. Epub 2025 May 9.

本文引用的文献

1
Body composition and cancer survival: a narrative review.人体成分与癌症生存:叙述性综述。
Br J Cancer. 2024 Feb;130(2):176-183. doi: 10.1038/s41416-023-02470-0. Epub 2023 Oct 27.
2
Role of body composition and metabolic parameters extracted from baseline F-FDG PET/CT in patients with diffuse large B-cell lymphoma.基线 F-FDG PET/CT 提取的体成分和代谢参数在弥漫性大 B 细胞淋巴瘤患者中的作用。
Ann Hematol. 2023 Oct;102(10):2779-2789. doi: 10.1007/s00277-023-05379-z. Epub 2023 Aug 2.
3
Quantitative PET-based biomarkers in lymphoma: getting ready for primetime.
基于定量 PET 的淋巴瘤生物标志物:准备迎接黄金时代。
Nat Rev Clin Oncol. 2023 Sep;20(9):640-657. doi: 10.1038/s41571-023-00799-2. Epub 2023 Jul 17.
4
Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B-cell lymphoma: results of a multicentric prospective cohort study.老年弥漫大 B 细胞淋巴瘤患者的肌肉减少症、老年综合评估和营养评估的预后相关性:一项多中心前瞻性队列研究的结果。
Ann Hematol. 2023 Jul;102(7):1811-1823. doi: 10.1007/s00277-023-05200-x. Epub 2023 Apr 14.
5
Relevance of body composition in phenotyping the obesities.人体成分分析在肥胖表型中的相关性。
Rev Endocr Metab Disord. 2023 Oct;24(5):809-823. doi: 10.1007/s11154-023-09796-3. Epub 2023 Mar 17.
6
Epidemiology of sarcopenia: Prevalence, risk factors, and consequences.肌少症的流行病学:患病率、风险因素和后果。
Metabolism. 2023 Jul;144:155533. doi: 10.1016/j.metabol.2023.155533. Epub 2023 Mar 11.
7
The Protective Effect of Theaflavins on the Kidney of Mice with Type II Diabetes Mellitus.茶黄素对 2 型糖尿病小鼠肾脏的保护作用。
Nutrients. 2022 Dec 31;15(1):201. doi: 10.3390/nu15010201.
8
Role of Radiomics Features and Machine Learning for the Histological Classification of Stage I and Stage II NSCLC at [F]FDG PET/CT: A Comparison between Two PET/CT Scanners.基于[F]FDG PET/CT的影像组学特征和机器学习在I期和II期非小细胞肺癌组织学分类中的作用:两台PET/CT扫描仪的比较
J Clin Med. 2022 Dec 29;12(1):255. doi: 10.3390/jcm12010255.
9
Clinical and prognostic role of 2-[F]FDG PET/CT and sarcopenia in treatment-naïve patients with T-cell lymphoblastic lymphoma.2-[F]FDG PET/CT及肌肉减少症在初治T细胞淋巴母细胞淋巴瘤患者中的临床及预后作用
Ann Hematol. 2022 Dec;101(12):2699-2709. doi: 10.1007/s00277-022-04988-4. Epub 2022 Sep 19.
10
Prognostic Impact of Adiposity in Hematological Malignancies: A Systematic Review and Meta-analysis.肥胖症在血液系统恶性肿瘤中的预后影响:系统评价和荟萃分析。
Clin Lymphoma Myeloma Leuk. 2022 Oct;22(10):726-734. doi: 10.1016/j.clml.2022.05.008. Epub 2022 May 29.